CVS Health (CVS) Tops Q1 EPS by 28c, Maintains FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health Reports First Quarter Results, Provides Update On COVID-19 Response 2020 Full Year EPS Guidance Remains Unchanged
May 6, 2020 6:30 AM EDTWOONSOCKET, R.I., May 6, 2020 /PRNewswire/ --
Swift and Decisive Response to COVID-19:
Support for employees, clients and communities across the country Testing thousands every day in collaboration with federal, state and local officials Consumer-driven health care model increases access to goods and servicesFirst Quarter Year-over-Year Highlights:
Total revenues increased 8.3% to $66.8 billion GAAP operating income increased 28.6% to $3.5 billion Adjusted operating income (1) increased 14.4% to $4.1 billion GAAP diluted earnings per share of $1.53 Adjusted EPS (2)... More